These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35765071)

  • 1. Single nucleotide polymorphism analysis of pvmdr-1 in Plasmodium vivax isolated from military personnel of Republic of Korea in 2016 and 2017.
    Bong JJ; Lee W; Lee CH; Park Q; Noh KT
    Malar J; 2022 Jun; 21(1):205. PubMed ID: 35765071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India.
    Joy S; Mukhi B; Ghosh SK; Achur RN; Gowda DC; Surolia N
    Malar J; 2018 Jan; 17(1):40. PubMed ID: 29351800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of single nucleotide polymorphisms of pvmdr1 and microsatellite genotype in Plasmodium vivax isolates from Republic of Korea military personnel.
    Chung DI; Jeong S; Dinzouna-Boutamba SD; Yang HW; Yeo SG; Hong Y; Goo YK
    Malar J; 2015 Sep; 14():336. PubMed ID: 26337571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of chloroquine in Plasmodium vivax and the pvmdr1 polymorphisms in the Republic of Korea under mass chemoprophylaxis.
    Kim YK; Kim C; Park I; Kim HY; Choi JY; Kim JM
    Am J Trop Med Hyg; 2011 Apr; 84(4):532-4. PubMed ID: 21460004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium vivax malaria: status in the Republic of Korea following reemergence.
    Park JW; Jun G; Yeom JS
    Korean J Parasitol; 2009 Oct; 47 Suppl(Suppl):S39-50. PubMed ID: 19885334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria control and chemoprophylaxis policy in the Republic of Korea Armed Forces for the previous 20 years (1997-2016).
    Im JH; Huh K; Yoon CG; Woo H; Lee JS; Chung MH; Klein TA; Jung J
    Malar J; 2018 Aug; 17(1):295. PubMed ID: 30111314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea.
    Lee KS; Kim TH; Kim ES; Lim HS; Yeom JS; Jun G; Park JW
    Am J Trop Med Hyg; 2009 Feb; 80(2):215-7. PubMed ID: 19190216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of Plasmodium vivax malaria in the Republic of Korea, 2008-2009: decrease followed by resurgence.
    Yeom JS; Jun G; Kim JY; Lee WJ; Shin EH; Chang KS; Bang JH; Oh S; Kang JY; Park JW
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):429-36. PubMed ID: 22560604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in chloroquine resistance-associated genes in Plasmodium vivax in Ethiopia.
    Golassa L; Erko B; Baliraine FN; Aseffa A; Swedberg G
    Malar J; 2015 Apr; 14():164. PubMed ID: 25889237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea army.
    Yeom JS; Ryu SH; Oh S; Choi DH; Song KJ; Oh YH; Lee JH; Kim YA; Ahn SY; Yang HY; Cha JE; Park JW
    J Korean Med Sci; 2005 Oct; 20(5):707-12. PubMed ID: 16224140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy of chloroquine chemoprophylaxis for vivax malaria among Republic of Korea military personnel.
    Jeong S; Yang HW; Yoon YR; Lee WK; Lee YR; Jha BK; Sylvatrie-Danne DB; Kim S; Jeong C; Kong HH; Goo YK; Hong Y; Chung DI
    Parasitol Int; 2013 Dec; 62(6):494-6. PubMed ID: 23850837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of primaquine terminal prophylaxis against late primary attacks of Plasmodium vivax malaria: a case-control study among troops of the Republic of Korea army.
    Park K; Kang JK
    Trans R Soc Trop Med Hyg; 2003; 97(4):441-2. PubMed ID: 15259477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium vivax mdr1 genotypes in isolates from successfully cured patients living in endemic and non-endemic Brazilian areas.
    Gomes LR; Almeida-de-Oliveira NK; de Lavigne AR; de Lima SR; de Pina-Costa A; Brasil P; Daniel-Ribeiro CT; Ménard D; Ferreira-da-Cruz Mde F
    Malar J; 2016 Feb; 15():96. PubMed ID: 26887935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological resistance of hydroxychloroquine for Plasmodium vivax malaria in the Republic of Korea.
    Lee SW; Lee M; Lee DD; Kim C; Kim YJ; Kim JY; Green MD; Klein TA; Kim HC; Nettey H; Ko DH; Kim H; Park I
    Am J Trop Med Hyg; 2009 Oct; 81(4):600-4. PubMed ID: 19815873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence rate of vivax malaria in the Republic of Korea.
    Moon KT; Kim YK; Ko DH; Park I; Shin DC; Kim C
    Trans R Soc Trop Med Hyg; 2009 Dec; 103(12):1245-9. PubMed ID: 19041109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK).
    Lee W; Lee SE; Lee MJ; Noh KT
    Malar J; 2020 Sep; 19(1):317. PubMed ID: 32873296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprophylaxis and the epidemiological characteristics of re-emergent P. vivax malaria in the Republic of Korea.
    Kim C; Shin DC; Yong TS; Oh DK; Kim RK; Park K; Suh IL
    Bull World Health Organ; 2006 Oct; 84(10):827-34. PubMed ID: 17128363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the in vitro sensitivity with associated drug resistance polymorphisms in Plasmodium vivax clinical isolates from Delhi, India.
    Matlani M; Kumar A; Singh V
    Exp Parasitol; 2021 Jan; 220():108047. PubMed ID: 33221328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of malaria vectors and incidence of vivax malaria at Korean army installations near the demilitarized zone, Republic of Korea.
    Chang KS; Yoo DH; Ju YR; Lee WG; Roh JY; Kim HC; Klein TA; Shin EH
    Malar J; 2016 May; 15(1):259. PubMed ID: 27150110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evaluation of pvdhfr and pvmdr-1 mutants in Plasmodium vivax isolates after treatment with sulfadoxine/pyrimethamine and chloroquine in Iran during 2001-2016.
    Parsaei M; Raeisi A; Spotin A; Shahbazi A; Mahami-Oskouei M; Hazratian T; Khorashad AS; Zaman J; Bazmani A; Sarafraz S
    Infect Genet Evol; 2018 Oct; 64():70-75. PubMed ID: 29929007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.